Full Press Release Details
BASKING RIDGE, N.J., March 18, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it will report fourth quarter and year ended December 31, 2018 financial results after the close of the market on Wednesday, March 27, 2019. Management will host a conference call and webcast at 4:30pm Eastern Daylight Time to discuss the financial results and answer questions.
| Wednesday, March 27th @ 4:30pm Eastern Daylight Time | |
| Domestic: | 877-407-4018 |
| International: | 201-689-8471 |
| Conference ID: | 13687710 |
| Webcast: | http://public.viavid.com/index.php?id=133315 |
About electroCore, Inc.
electroCore, Inc. is a commercial-stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology and rheumatology. The company’s initial targets are the preventative treatment of cluster headache and acute treatment of migraine and episodic cluster headache.
For more information, visit www.electrocore.com.
LifeSci Public Relations